Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: circulatory collapse; Depressed level of consciousness; Oxygen saturation decreased; Atrial fibrillation; Hypotension; Wheezy bronchitis; pulse irregular, around 70; bodytemperature 37,7 degrees Celcius, elevated to 38,5; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB and received via Regulatory Authority, SE-MPA-2021-001856. A 92-year-old male patient received the first dose of BNT162B2 (COMIRNATY, Lot. EJ6134), intramuscularly in arm right in Jan2021 at 0.3 mL, single for COVID-19 immunization. Medical history included angiopathy, heart disease, unspecified, parkinson''s disease, type 2 diabetes mellitus, and hypersensitivity towards penicillins. The patient had a special home care living and was reported in Nov2020 to have been more tired sleeping a lot in the middle of the day, respiratory arrest and earlier adrenal insufficiency, probably iatrogenic because of high dose cortisone. Concomitant medications included cyanocobalamin (BETOLVEX), warfarin, metoprolol succinate (SELOKEN), furosemide (FURIX), carbidopa/levodopa (SINEMET), simvastatin, digoxin, and carbidopa/levodopa (LEVOCAR). The patient developed atrial fibrillation, wheezy bronchitis, hypotension, oxygen saturation decreased and depressed level of consciousness. The patient''s Pk (INR) was checked before the vaccination with BNT162B2 and it was stable. During the night, day 2 after the vaccination, the patient started to be ill with wheezy bronchitis, blood pressure, 91/33, pulse irregular, around 70, body temperature 37.7 degrees Celcius, elevated to 38.5, respiratory rate 24, saturation 73 and he became depressed level of consciousness. The patient got oxygen and was given palliative care. It could be an adverse reaction and the immune system was working against the vaccination. Reactions started 2 days after the vaccination with BNT162B2. The patient died 4 days after the vaccination with BNT162B2. Cause of death was circulatory collapse. The patient died on an unspecified date, in 2021. Outcome of events circulatory collapse, depressed level of consciousness, oxygen saturation decreased, atrial fibrillation, hypotension, and wheezy bronchitis was fatal, and of events pulse irregular, around 70, and body temperature 37.7 degrees Celcius, elevated to 38.5 was unknown. No autopsy was performed. Follow-up (11Feb2021): New information received from a contactable physician from the Agency Regulatory Authority-WEB includes: information on autopsy. Follow-up attempts completed. No further information expected.; Reported Cause(s) of Death: Circulatory collapse; depressed level of consciousness; oxygen saturation decreased; atrial fibrillation; hypotension; wheezy bronchitis
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166